Vanguard Group Inc Neuro Pace Inc Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Neuro Pace Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,198,078 shares of NPCE stock, worth $12.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,198,078
Previous 1,057,295
13.32%
Holding current value
$12.2 Million
Previous $11.8 Million
24.45%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding NPCE
# of Institutions
93Shares Held
24.6MCall Options Held
1.8KPut Options Held
300-
Orbimed Advisors LLC San Diego, CA3.41MShares$34.7 Million1.3% of portfolio
-
Polar Capital Holdings PLC London, X02.97MShares$30.3 Million0.24% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.61MShares$26.6 Million2.65% of portfolio
-
Morgan Stanley New York, NY2.53MShares$25.8 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN1.58MShares$16.2 Million2.5% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $253M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...